Your browser doesn't support javascript.
loading
Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia.
Alsawah, Fares; Benitez, Lydia; Choi, Sarah; Marini, Bernard; Perissinotti, Anthony; Skyles, Amy; Burke, Patrick; Pettit, Kristen; Crouch, Ashley; Fox, Heather; Bixby, Dale.
Afiliación
  • Alsawah F; Department of Internal Medicine and.
  • Benitez L; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI.
  • Choi S; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI; and.
  • Marini B; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI.
  • Perissinotti A; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI.
  • Skyles A; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, Ann Arbor, MI.
  • Burke P; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.
  • Pettit K; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.
  • Crouch A; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.
  • Fox H; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.
  • Bixby D; Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI.
Blood Adv ; 3(21): 3333-3336, 2019 11 12.
Article en En | MEDLINE | ID: mdl-31698446
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Prolinfocítica de Células T / Alemtuzumab / Antineoplásicos Inmunológicos / Neoplasias Meníngeas Tipo de estudio: Diagnostic_studies Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Prolinfocítica de Células T / Alemtuzumab / Antineoplásicos Inmunológicos / Neoplasias Meníngeas Tipo de estudio: Diagnostic_studies Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article